ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

circRNA_103615 contributes to tumor progression and cisplatin resistance in NSCLC by regulating ABCB1

Liang, Hongguang; Lin, Zelong; Lin, Huiwen; Zhao, Li; Huang, Weihua*广州中医药大学; 南方医科大学; 1
Experimental and Therapeutic Medicine2021-9DOI: 10.3892/etm.2021.10366
6被引7阅读
引用收藏
分享

摘要

Lung cancer is one of the main causes of tumor lethality worldwide. Circular RNAs (circRNAs) have essential roles in tumor progression. However, in non-small cell lung carcinoma (NSCLC), the role of circRNAs remains unknown. In the present study, the expression, function and molecular mechanisms of a new circRNA, circRNA_103615, were investigated in NSCLC. Reverse transcription-quantitative PCR (RT-qPCR) was used to detect circRNA_103615 expression levels in NSCLC and normal tissues, as well as in NSCLC cell lines. MTT assay, flow cytometric assay, colony formation assay, and cell migration and invasion assays were used to examine the function of circRNA_103615 in NSCLC cells. MTT assay, colony formation assay, RT-qPCR, and western blotting were used to detect the effect of circRNA_103615 on cisplatin resistance. The results demonstrated that NSCLC cell lines and tissues had increased levels of circRNA_103615 compared with normal cells and normal tissues, respectively. Functionally, silencing of circRNA_103615 by small interfering RNA resulted in suppression of cell growth, migration, and invasion, but promotion of cell apoptosis. In addition, the cisplatin resistance of NSCLC was reversed by the silencing of circRNA_103615. Notably, ATP binding cassette subfamily Bmember 1 (ABCB1) expression was significantly decreased following circRNA_103615 knockdown, and ABCB1 overexpression reversed the effects of circRNA_103615 silencing on NSCLC cisplatin resistance. Thus, the present study indicated that circRNA_103615 may serve as a critical oncogene and potential novel biomarker in NSCLC, as well as a potential cisplatin resistance promoter, by regulating ABCB1 expression.

学科与关键词

关键词
circRNA_103615cisplatin resistanceATP binding cassette subfamily B member 1non-small cell lung carcinoma
相关
加载中…
  • Insights Into circRNAs: Functional Roles in Lung Cancer Management and the Potential Mechanisms
    Feng, Bing; Zhou, Hao; Wang, Ting; Lin, Xinrong; Lai, Yongting; Chu, Xiaoyuan; Wang, Rui*Frontiers in Cell and Developmental Biology, 2021, 9: 636913.被引 6
  • Mechanism of RNA circHIPK3 Involved in Resistance of Lung Cancer Cells to Gefitinib
    Zhao, Yi; Zhang, Caiming; Tang, Haibo; Wu, Xiaomin; Qi, Qiugan*Biomed Research International, 2022, 2022: 4541918.被引 3
  • Circ_0072088 knockdown contributes to cisplatin sensitivity and inhibits tumor progression by miR-944/LASP1 axis in non-small cell lung cancer
    Zhang, Lei; Wu, Yuanzhou; Hou, Chunyang; Li, Fangzhi*Journal of Gene Medicine, 2022, 24(5): e3414.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Experimental and Therapeutic Medicine
发表日期
2021-09
卷期
第 22 卷, 第 3 期
页码
934
DOI
10.3892/etm.2021.10366
语言
ENGLISH
期刊收录
NSL
期刊等级
4区
成果收录
SCIE

作者

  • L

    Liang, Hongguang (第一作者)

    1 · guangzhou univ chinese med

  • L

    Lin, Zelong

    southern med univ

查看全部 5 位作者收起作者
  • L

    Lin, Huiwen

    1 · guangzhou univ chinese med

  • Z

    Zhao, Li

    1 · guangzhou univ chinese med

  • H

    Huang, Weihua (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417